Published in J Exp Med on February 01, 1977
Immunological regulation of experimental cutaneous leishmaniasis. III. Nature and significance of specific suppression of cell-mediated immunity in mice highly susceptible to Leishmania tropica. J Exp Med (1980) 2.97
Enhancement of delayed hypersensitivity reaction with varieties of anti-cancer drugs. A common biological phenomenon. J Exp Med (1981) 1.40
Suppressor T cells for delayed-type hypersensitivity to Japanese encephalitis virus. Immunology (1984) 1.11
Induction of suppressor cells in Japanese encephalitis virus infected mice. Br J Exp Pathol (1983) 1.09
Distinction between suppressors of the delayed-type hypersensitivity and the humoral response to sheep erythrocytes. Immunology (1978) 1.09
Cyclophosphamide eliminates suppressor T cells in age-associated central regulation of delayed hypersensitivity in mice. J Exp Med (1979) 1.07
Influence of dietary protein restriction on the delayed-type hypersensitivity response to sheep red blood cells in mice. Immunology (1983) 0.84
Two distinct types of cellular mechanisms in the development of delayed hypersensitivity in mice: requirement of either mast cells or macrophages for elicitation of the response. Immunology (1993) 0.79
MD41, a novel T helper 0 clone, mediates mast-cell dependent delayed-type hypersensitivity in mice. Immunology (2002) 0.77
Suppression of tuberculin hypersensitivity during influenza infection in mice. Infect Immun (1979) 0.76
Effects of adult thymectomy on the contact sensitivity skin reaction and the unresponsiveness caused by feeding contact sensitizing agents. Immunology (1981) 0.75
Experimental production of pulmonary granulomas; II. Age dependency and immune modulation of granuloma production. Br J Exp Pathol (1982) 0.75
The regulatory influence of activated T cells on B cell responses to antigen. Adv Immunol (1972) 9.43
Immunologic complementation between thymus and marrow cells--a model for the two-cell theory of immunocompetence. Transplant Rev (1969) 6.39
Infectious immunological tolerance. Immunology (1971) 5.30
Evidence for the existence of two functionally distinct types of cells which regulate the antibody response to type 3 pneumococcal polysaccharide. J Immunol (1970) 3.94
Suppressor T cells. J Immunol (1972) 3.92
Synergy among lymphoid cells mediating the graft-versus-host response. 3. Evidence for interaction between two types of thymus-derived cells. J Exp Med (1972) 3.77
Biological expressions of lymphocyte activation. II. Generation of a population of thymus-derived suppressor lymphocytes. J Exp Med (1973) 3.50
Regulation of homocytotropic antibody formation in the rat. VI. Inhibitory effect of thymocytes on the homocytotropic antibody response. J Immunol (1971) 3.48
Synergy during in vitro cytotoxic allograft responses. I. Evidence for cell interaction between thymocytes and peripheral T cells. J Exp Med (1973) 3.24
Feedback inhibition of specifically sensitized lymphocytes. J Exp Med (1974) 3.11
T cell-dependent suppression of an anti-hapten antibody response. Transplant Rev (1975) 3.06
Depression of the T cell phenomenon of contact sensitivity by T cells from unresponsive mice. Nature (1973) 2.85
Enhancement of the antibody response to type 3 pneumococcal polysaccharide in mice treated with antilymphocyte serum. J Immunol (1970) 2.59
Selective roles of thymus-derived lymphocytes in the antibody response. I. Differential suppressive effect of carrier-primed T cells on hapten-specific IgM and IgG antibody responses. J Exp Med (1974) 2.50
Synergism between subpopulations of thymus-derived cells mediating the proliferative and effector phases of the mixed lymphocyte reaction. Proc Natl Acad Sci U S A (1973) 2.48
Loss with age in NZB-W mice of thymic suppressor cells in the graft-vs-host reaction. J Immunol (1974) 2.45
Enhanced immune responsiveness to a thymus-independent antigen early after adult thymectomy: evidence for short-lived inhibitory thymus-derived cells. Eur J Immunol (1972) 2.34
The splenic suppressor cell. I. Activity of thymus-dependent adherent cells: changes with age and stress. J Immunol (1974) 2.30
Immuno-regulatory role of spleen localizing thymocytes. J Immunol (1974) 2.27
Regulatory mechanisms in cell-mediated immune responses. I. Regulation of mixed lymphocyte reactions by alloantigen-activated thymus-derived lymphocytes. J Exp Med (1974) 2.26
Synergy among lymphoid cells mediating the graft-versus-host response. I. Synergy in graft-versus-host reactions produced by cells from NZB-Bl mice. J Exp Med (1970) 2.15
Effect of thymectomy in adult mice on immunological responsiveness. Nature (1965) 1.91
Regulation of the immune response by subclasses of T lymphocytes. II. The effect of adult thymectomy upon humoral and cellular responses in mice. Eur J Immunol (1975) 1.79
Regulation of the immune response by subclasses of T lymphocytes. I. Interactions between pre-killer T cells and regulatory T cells obtained from peripheral lymphoid tissues of mice. Eur J Immunol (1975) 1.72
Delayed effect of thymectomy in adult life on immunological competence. Nature (1965) 1.70
The thymic suppressor cell. I. Separation of subpopulations with suppressor activity. J Exp Med (1974) 1.42
Supressor cells in the graft vs host reaction. J Immunol (1973) 1.41
Induction of T-lymphocyte responses to a small molecular weight antigen. III. T-T cell interactions to determinants linked together: suppression vs. enhancement. J Exp Med (1975) 1.32
Preferential development by mice of delayed hypersensitivity to purified basic proteins. J Allergy (1968) 1.26
Investigation of the mechanisms by whick "enhancing" antiserum prevents induction of delayed hypersensitivity to protein antigens in mice. J Allergy (1969) 1.19
Thymus cell population exerting a regulatory function in the immune response of mice to polyvinyl pyrrolidone. Cell Immunol (1974) 1.15
Physical separation of "suppressor" from "helper" thymocytes. J Immunol (1975) 0.92
Antigenic specificities of antibodies suppressing induction of delayed hypersensitivity in mice to dinitrophenylated proteins. Immunology (1973) 0.86
Heterogeneity in the development of cytotoxic T lymphocytes in vitro revealed by sensitivity to hydrocortisone. J Exp Med (1975) 0.80
Formation process of autophagosome is traced with Apg8/Aut7p in yeast. J Cell Biol (1999) 9.33
Autophagy in yeast demonstrated with proteinase-deficient mutants and conditions for its induction. J Cell Biol (1992) 8.33
Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J Virol Methods (1988) 7.74
Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell (1997) 6.70
Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol (2000) 5.94
Sequence of simian immunodeficiency virus from African green monkey, a new member of the HIV/SIV group. Nature (1988) 5.09
Apg9p/Cvt7p is an integral membrane protein required for transport vesicle formation in the Cvt and autophagy pathways. J Cell Biol (2000) 4.30
Cvt9/Gsa9 functions in sequestering selective cytosolic cargo destined for the vacuole. J Cell Biol (2001) 4.25
High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicol Sci (2001) 4.02
Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci U S A (1997) 3.88
Aminopeptidase I is targeted to the vacuole by a nonclassical vesicular mechanism. J Cell Biol (1997) 3.81
Solution structure of a specific DNA complex of the Myb DNA-binding domain with cooperative recognition helices. Cell (1994) 3.74
Isolation of simian immunodeficiency virus from African green monkeys and seroepidemiologic survey of the virus in various non-human primates. Int J Cancer (1988) 3.60
Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci U S A (1990) 3.52
Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines. Antiviral Res (1987) 3.46
Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice. Nat Genet (1999) 3.07
Molecular cloning of a novel human CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1, CCR7. J Biol Chem (1997) 2.79
Expression of an antigen associated with acute lymphoblastic leukemia in human leukemia-lymphoma cell lines. J Natl Cancer Inst (1978) 2.66
The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem (1997) 2.59
Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein. Ann Neurol (1998) 2.47
Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the beta4 integrin and the PI3k pathway. Oncogene (2006) 2.36
Apg5p functions in the sequestration step in the cytoplasm-to-vacuole targeting and macroautophagy pathways. Mol Biol Cell (2000) 2.33
Exploring postinfarction reentrant ventricular tachycardia with entrainment mapping. J Am Coll Cardiol (1997) 2.27
Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein. J Biol Chem (2000) 2.27
Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro. Antiviral Res (1987) 2.27
Sequences and coding strategies of the S RNAs of Toscana and Rift Valley fever viruses compared to those of Punta Toro, Sicilian Sandfly fever, and Uukuniemi viruses. Virology (1991) 2.18
Phosphonylmethoxyethyl purine derivatives, a new class of anti-human immunodeficiency virus agents. Antimicrob Agents Chemother (1988) 2.16
Two E-rosette-forming lymphoid cell lines. Int J Cancer (1978) 2.09
Derepression of arylsulfatase synthesis in Aerobacter aerogenes by tyramine. J Bacteriol (1973) 2.07
Yes-associated protein (YAP) functions as a tumor suppressor in breast. Cell Death Differ (2008) 2.03
O-alkyl-l-homoserines: three new amino acids formed from alcohols by Corynebacterium ethanolaminophilum sp. nov. Biochem Biophys Res Commun (1967) 2.02
Catabolite repression and derepression of arylsulfatase synthesis in Klebsiella aerogenes. J Bacteriol (1974) 2.01
Chromogenic substrates for horseshoe crab clotting enzyme. Its application for the assay of bacterial endotoxins. Haemostasis (1978) 1.96
Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol (1998) 1.93
Repression and induction of arylsulphatase synthesis in Aerobacter aerogenes. Biochem J (1964) 1.91
Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event. Proc Natl Acad Sci U S A (1992) 1.89
Relation between smoking status of physicians and their enthusiasm to offer smoking cessation advice. Intern Med (1997) 1.88
Selective expression of liver and activation-regulated chemokine (LARC) in intestinal epithelium in mice and humans. Eur J Immunol (1999) 1.86
Overexpression of matrix metalloproteinase 9 gene in hepatocellular carcinoma with invasive potential. Hepatology (1996) 1.86
The role of choline sulphate in the sulphur metabolism of fungi. Biochem J (1960) 1.85
A novel human CC chemokine PARC that is most homologous to macrophage-inflammatory protein-1 alpha/LD78 alpha and chemotactic for T lymphocytes, but not for monocytes. J Immunol (1997) 1.83
Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer. Br J Cancer (1998) 1.82
Regulation of arylsulfatase synthesis by sulfur compounds in Klebsiella aerogenes. J Bacteriol (1975) 1.81
Ototoxicity of neomycin and its penetration through the round window membrane into the perilymph. Ann Otol Rhinol Laryngol (1986) 1.80
Marked in vivo antiretrovirus activity of 9-(2-phosphonylmethoxyethyl)adenine, a selective anti-human immunodeficiency virus agent. Proc Natl Acad Sci U S A (1989) 1.74
Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector. J Biol Chem (1996) 1.74
Introduction of bacteriophage Mu into bacteria of various genera and intergeneric gene transfer by RP4::Mu. J Bacteriol (1981) 1.73
Modulatory effect of antibiotics on cytokine production by human monocytes in vitro. Antimicrob Agents Chemother (1996) 1.73
Mortality, major cause of moribundity, and spontaneous tumors in CD-1 mice. Toxicol Pathol (1988) 1.73
Endoscopic ultrasonography and endoscopy for staging depth of invasion in early gastric cancer: a pilot study. Gastrointest Endosc (1997) 1.72
Alveolar macrophages that phagocytose apoptotic neutrophils produce hepatocyte growth factor during bacterial pneumonia in mice. Am J Respir Cell Mol Biol (2001) 1.71
Morphologic studies of the liver cell dysplasia. Cancer (1983) 1.70
Both 2',3'-dideoxythymidine and its 2',3'-unsaturated derivative (2',3'-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro. Biochem Biophys Res Commun (1987) 1.67
Geranylgeranylated SNAREs are dominant inhibitors of membrane fusion. J Cell Biol (2000) 1.66
Immunohistologic study of the ruptured intervertebral disc of the lumbar spine. Spine (Phila Pa 1976) (1996) 1.66
Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor. Hepatology (1996) 1.65
A novel lead for specific anti-HIV-1 agents: 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine. J Med Chem (1989) 1.62
Regulation of tyramine oxidase synthesis in Klebsiella aerogenes. J Bacteriol (1976) 1.62
Curdlan: a bacterial gel-forming beta-1,3-glucan. Arch Biochem Biophys (1968) 1.59
Intra-arterial infusion of fasudil hydrochloride for treating vasospasm following subarachnoid haemorrhage. Acta Neurochir (Wien) (1999) 1.57
Immunological study of the regulation of cellular arylsulfatase synthesis in Klebsiella aerogenes. J Bacteriol (1977) 1.57
Complete nucleotide sequence of a methylcholanthrene-inducible cytochrome P-450 (P-450d) gene in the rat. J Biol Chem (1985) 1.56
Altered gene expression and secretion of interleukin-6 in stromal cells derived from endometriotic tissues. Fertil Steril (2000) 1.55
Genetic control of arylsulfatase synthesis in Klebsiella aerogenes. J Bacteriol (1977) 1.55
Intraglomerular C3 synthesis in human kidney detected by in situ hybridization. J Am Soc Nephrol (1996) 1.54
A new cause of female pseudohermaphroditism: placental aromatase deficiency. J Clin Endocrinol Metab (1991) 1.54
Evaluation and treatment of swallowing impairments. Am Fam Physician (2000) 1.53
Truncoumbilical bypass of the portal vein in radical resection of biliary tract tumour involving the hepatic duct confluence. Br J Surg (1990) 1.53
3'-substituted 2',3'-dideoxynucleoside analogues as potential anti-HIV (HTLV-III/LAV) agents. J Med Chem (1987) 1.53
Tyramine oxidase and regulation of arylsulfatase synthesis in Klebsiella aerogenes. J Bacteriol (1977) 1.51
Surgical techniques and reattachment rates in retinal detachment due to macular hole. Arch Ophthalmol (1990) 1.50
The von Hippel-Lindau tumor suppressor protein mediates ubiquitination of activated atypical protein kinase C. J Biol Chem (2001) 1.50
Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein. Virology (1997) 1.49
Formation of O-ethylhomoserine by bacteria. J Bacteriol (1968) 1.49
Comparative efficacy of antiherpes drugs against various strains of varicella-zoster virus. J Infect Dis (1983) 1.47
Comparison of the free and DNA-complexed forms of the DNA-binding domain from c-Myb. Nat Struct Biol (1995) 1.46
Genetic mapping of tyramine oxidase and arylsulfatase genes and their regulation in intergeneric hybrids of enteric bacteria. J Bacteriol (1978) 1.45
Fatty liver in a case with heterozygous familial hypobetalipoproteinemia. Am J Gastroenterol (1997) 1.45
The in vitro and in vivo anti-retrovirus activity, and intracellular metabolism of 3'-azido-2',3'-dideoxythymidine and 2',3'-dideoxycytidine are highly dependent on the cell species. Biochem Pharmacol (1988) 1.45
Two major antigenic polypeptides of molluscum contagiosum virus. J Infect Dis (1998) 1.44
O-alkylhomoserine and methionine biosynthesis in Corynebacterium. J Biochem (1969) 1.44
Synthesis and antiviral activity of 6-benzyl analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agents. J Med Chem (1995) 1.43
[The desensitization therapy in children with nasal allergy to house dust]. Nihon Jibiinkoka Gakkai Kaiho (1989) 1.42
Transvaginal ultrasound-guided follicular aspiration in the management of anovulatory infertility associated with polycystic ovaries. Fertil Steril (1991) 1.41
Enhancement of delayed hypersensitivity reaction with varieties of anti-cancer drugs. A common biological phenomenon. J Exp Med (1981) 1.40
Utility of duplex Doppler ultrasound in evaluating portal hypertension in children. J Pediatr Gastroenterol Nutr (1995) 1.40
Enzyme-linked immunosorbent assays for detection of antibodies to Ebola and Marburg viruses using recombinant nucleoproteins. J Clin Microbiol (2001) 1.39
Enhancement of delayed hypersensitivity by depletion of suppressor T cells with cyclophosphamide in mice. Nature (1976) 1.39
Solution structure of the DNA binding domain of a nucleoid-associated protein, H-NS, from Escherichia coli. FEBS Lett (1995) 1.38
Efficacy of a new hemostatic device, Adapty , after transradial coronary angiography and intervention. J Invasive Cardiol (2000) 1.38
Lymphangioma in the small intestine: report of a case and review of the Japanese literature. Surg Today (1992) 1.38
Antigen-binding cells in normal mouse thymus. Science (1970) 1.37
Anti-retrovirus activity of 3'-fluoro- and 3'-azido-substituted pyrimidine 2',3'-dideoxynucleoside analogues. Biochem Pharmacol (1988) 1.37
Extended right hepatic lobectomy: combined resection of inferior vena cava and its reconstruction by EPTFE graft (Gore-Tex). Case report. Acta Chir Scand (1988) 1.36
Design of MKC-442 (emivirine) analogues with improved activity against drug-resistant HIV mutants. J Med Chem (1999) 1.36